GENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

JOURNAL OF GENETICS, published by the Indian Academy of Sciences, is a pivotal platform for researchers and scholars in the field of genetics. With its long-standing history dating back to 1910, this journal has consistently contributed to the academic discourse through the rigorous publication of original research, reviews, and case studies. Despite its current classification in the Q4 quartile for the 2023 metrics in Genetics, the journal plays a critical role in advancing our understanding of genetic principles, experimental methodologies, and innovations. Spanning a diverse array of topics, the journal aims to foster scholarly exchange and collaboration within the global genetics community. For researchers aiming to publish their work, accessing the journal’s comprehensive archives, which include publications from as early as 1910 to the present day, offers a valuable perspective on the evolution of genetic research. As it continues to adapt to the changing landscape of scientific inquiry, JOURNAL OF GENETICS remains a significant resource for students, professionals, and academics dedicated to exploring the complexities of genetics.

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.